Non Interventional Study (NIS) Regarding the Application of Ectoin Mund- & Rachenspray in Patients With Acute Laryngitis and/or Acute Pharyngitis
NCT ID: NCT02160912
Last Updated: 2015-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
95 participants
OBSERVATIONAL
2014-02-28
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients are treated with Ectoin Mund- \& Rachenspray 1% or Emser Pastillen according to the demands of the physician and the instructions for use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)
NCT04203810
Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
NCT01684540
Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis
NCT03693976
Iota-Carrageenan Nasal Spray in Common Cold
NCT01944631
Ambroxol Spray Sore Throat Study
NCT01361802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ectoin Mund- & Rachenspray
treatment with Ectoin Mund- \& Rachenspray 1%
No interventions assigned to this group
Emser Pastillen
treatment with Emser Pastillen
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bitop AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ralph Mösges, MD
Role: PRINCIPAL_INVESTIGATOR
Klinikum der Universität zu Köln
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norbert Pasch-Facharzt für HNO Heilkunde
Aachen, , Germany
HNO Praxis Aachen Brand
Aachen, , Germany
Taufik Shahab -Facharzt für HNO Heilkunde
Cologne, , Germany
Bey - Facharzt f. HNO Heilkunde
Cologne, , Germany
HNO-Praxis Peter Hinterkausen & Dr. med. Eva Bottler-Neufert
Cologne, , Germany
HNo Praxis Dr. Uta Thieme
Duisburg, , Germany
Dr. Lenzenhuber-Fachärztin für HNO Heilkunde
Jülich, , Germany
Wilhelm Schütz -Facharzt für HNO Heilkunde
Jülich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EctMRS/aLR/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.